1. Begent, R. H. J., Ledermann, J. A., Bagshawe, K. D., Green, A. J., Kelly, A. M. B., Une, D., Glaser, M. G., Dewji, M. R., Baker, T. S., and Secher, D. S., 1990, Chimeric B72 J antibody for repeated radio~immunotherapy of colorectal carcinoma, Fifth International Conference on Monoclonal Antibody Immunoconju gates for Cancer, March 15–17, San Diego, p. 73.
2. Blakely, D. C., Watson, G. J., Knowles, P. P., and Thorpe, P. E., 1987, Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1,1 antibody, Cancer Res. 47:947–952.
3. Blakely, D. C., Skilleter, D. N., Price, R. J., Watson, G. J., Hart, L. I., Newell, D. R., and Thorpe, P. E., 1988, Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells, Cancer Res. 48:7072–7078.
4. Bourne, B. J. P., Casellas, P., Blythman, H. E., and Jansen, F. K., 1986, Study of the plasma clearance of antibody-ricin-A-chain immunotoxins, Eur, J, Biochem. 155:1–10.
5. Brodsky, F. M., 1988, Monoclonal antibodies as magic bullets, Pbarm. Res. 5:1–9.